Neoadjuvant hormone therapy and external-beam radiation for localized high-risk prostate cancer: The importance of PSA nadir before radiation
- 1 August 2005
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 62 (5) , 1309-1315
- https://doi.org/10.1016/j.ijrobp.2005.01.001
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- The Efficacy and Sequencing of a Short Course of Androgen Suppression on Freedom From Biochemical Failure When Administered With Radiation Therapy for T2-T3 Prostate CancerJournal of Urology, 2004
- How low is the α/β ratio for prostate cancer?International Journal of Radiation Oncology*Biology*Physics, 2003
- Effect of sequencing of androgen deprivation and radiotherapy on prostate cancer growthInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialThe Lancet, 2002
- Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 2001
- The external radiotherapy with three-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.Journal of Clinical Oncology, 1998
- Androgen deprivation and radiation therapy: Sequencing studies using the shionogi in vivo tumor systemInternational Journal of Radiation Oncology*Biology*Physics, 1997